Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors - Jackson, Christopher B.; Noorbakhsh, Seth I.; Sundaram, Ranjini K.; Kalathil, Aravind N.; Ganesa, Sachita; Jia, Lanqi; Breslin, Hank; Burgenske, Danielle M.; Gilad, Oren; Sarkaria, Jann N.; Bindra, Ranjit S. (Cancer research (Chicago, Ill.), 2019)